Tag Archives: CLIA

Clinical Genomics, a leading provider of liquid biopsy cancer testing solutions, today announced the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Clinical Genomics Pathology Inc., based on results...

World’s First and Only Test Analyzing Genetic Information from Exosomes Via a Simple Urine Collection Requiring No Digital Rectal Exam Potential to Avoid Over One Million Unnecessary Prostate Biopsies Each Year Worldwide Exosome Diagnostics, Inc. announced the launch of its ...

THOROLD, ON, March 2, 2016 /CNW/ – Norgen Biotek Corp., an innovative Canadian biotechnology company focusing on advancing powerful tools for DNA, RNA and protein stabilization and purification, today announced the signing of a supplier agreement with Biodesix, Inc. to ...

Now Has Six Liquid Biopsy CLIA Cancer Panels that Leverage Exceptional Sensitivity of Multiplexed ICE COLD-PCR to Detect Actionable Mutations in RAS and PIK3CA Genes Relevant to Treatment of Lung and Colorectal Cancers OMAHA, Neb.–(BUSINESS WIRE)–Transgenomic, Inc. (NASDAQ: TBIO) today ...

from GenomeWeb by Molika Ashford NEW YORK (GenomeWeb) – Hot on the heels of several other new liquid biopsy companies, Circulogene — a new firm offering NGS detection of cancer mutations using finger stick-volume blood samples — announced recently that ...

Company centralizing U.S. operations ahead of cancer liquid biopsy test launches in 2015 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced that it has opened a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in Cambridge, ...